ANTI-GDF-15 ANTIBODIES

Monoclonal antibodies that bind and inhibit the activity of human GDF15 are disclosed. The antibodies can be used to treat body weight loss, including cachexia, associated with the over-expression of human GDF15.

Saved in:
Bibliographic Details
Main Authors Lerner, Lorena, Chen, Ting, Weng, Zhigang, Tao, Nianjun, Winston, JR., William M, Poling, Laura, Weiler, Solly, Gyuris, Jeno, Abbott, Sandra, Liu, Qing, Bai, Ailin, Chiu, Maria Isabel
Format Patent
LanguageEnglish
Published 08.04.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Monoclonal antibodies that bind and inhibit the activity of human GDF15 are disclosed. The antibodies can be used to treat body weight loss, including cachexia, associated with the over-expression of human GDF15.
Bibliography:Application Number: US202016824034